Pulse Oximetry in the diagnosis of critical congenital cardiac disease
1. Introduction
Pulse oximetry screening is a non-invasive, bedside test used in asymptomatic newborns to detect subclinical hypoxemia, which may indicate duct-dependent "critical" congenital heart disease (CCHD). It aims to identify lesions before the ductus arteriosus closes and cardiovascular collapse occurs.
2. Screening Targets
- Primary Targets (7 defects):
- Hypoplastic left heart syndrome (HLHS),
- Pulmonary atresia,
- Tetralogy of Fallot (TOF),
- Total anomalous pulmonary venous return (TAPVR),
- Transposition of the great arteries (TGA),
- Tricuspid atresia,
- Truncus arteriosus.
- Secondary Targets: Coarctation of the aorta, Interrupted aortic arch, and Ebsteinβs anomaly.
3. Methodology
- Timing: Ideally performed between 24 and 48 hours of life. (Screening <24 hours increases false-positive rates due to transitional circulation).
- Pre-requisites: Infant should be quiet, alert, and off supplemental oxygen.
- Sites: 1. Pre-ductal: Right hand.
2. Post-ductal: Either foot. - Equipment: Use of "motion-tolerant" pulse oximeters validated for neonatal use.
4. Updated Screening Algorithm (AAP 2025)
A pass requires
-
PASS: *
in BOTH right hand and foot. - AND
difference between sites.
- AND
-
IMMEDIATE FAIL:
in EITHER right hand or foot.
-
INDETERMINATE (Repeat after 1 hour):
is in either site OR difference between sites. - Action: Repeat screen once (Note: 2025 update reduces retests to one).
- If the repeat screen does not meet "Pass" criteria, it is a FAIL.
5. Evaluation of Failed Screen
Infants failing the screen require urgent medical evaluation:
- Physical Exam: Assess for murmurs, femoral pulses, and respiratory distress.
- Differential Diagnosis: Sepsis, Pneumonia, Persistent Pulmonary Hypertension (PPHN), or CCHD.
- Definitive Test: Urgent Echocardiogram (read by a pediatric cardiologist) is mandatory if no non-cardiac cause for hypoxemia is identified.
6. Limitations
- Does not detect all CCHDs (e.g., Coarctation may pass if there is no significant ductal shunting).
- High false-positive rates in high-altitude regions.